Search

everythinglearnresearchcommunity

for

Search:↓

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

The document is a detailed guide on skin conditions and treatments for dermatologists.

Cedrol may prevent hair loss caused by chemotherapy better than minoxidil.

Ginseng and its compounds may help hair growth and prevent hair loss, but more human trials are needed to confirm this.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

The book provides an overview of new trends and techniques in cosmetic dermatology.

A boy on a ketogenic diet and anti-epileptic drugs developed skin issues due to stopping vitamin supplements, which improved with proper supplementation.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Minoxidil effectively treats severe hypertension but may cause side effects, so careful monitoring is needed.

Cancer can hijack the body's cell repair system to promote tumor growth, and targeting this process may improve cancer treatments.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

Activating NRF2 might help treat hair disorders by improving antioxidant defenses.

Allergic reactions to blood thinners are rare but can be serious, requiring careful management and alternative treatments.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Finasteride caused a rare skin rash in a man, which improved after stopping the medication.

Finasteride has a higher risk of reproductive side effects than minoxidil.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

Chemotherapy causes complex changes in hair follicle cells that can lead to hair loss.

Stem cell therapies show promise for treating various diseases but face challenges in clinical use and require better monitoring techniques.

QR 678 and QR 678 Neo are safe and promote hair growth, potentially helping chemotherapy-induced hair loss.

HIV can cause skin disorders, which are often the first sign of infection, especially in people with darker skin.

Some psychiatric drugs can cause severe hair loss, especially valproic acid, and it's more likely in women or those with thyroid issues or past hair loss.

Fenugreek seed extract in a nanoparticle gel could be a promising new treatment for hair loss.